Xenetic Biosciences (XBIO) FCF Margin Growth (3y) (2019 - 2026)
Xenetic Biosciences (XBIO) FCF Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -3,088.00 |
| 10 | Xenetic Biosciences | 8.01 Mn | 1.54 Mn | - | 4,091.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,091.00 |
| Mar 31, 2026 | 7,877.00 |
| Dec 31, 2025 | 1,197.00 |
| Sep 30, 2025 | 27,222.00 |
| Jun 30, 2025 | 10,916.00 |
| Mar 31, 2025 | 36,855.00 |
| Dec 31, 2024 | 55,977.00 |
| Sep 30, 2024 | 22,113.00 |
| Jun 30, 2024 | 18,042.00 |
| Mar 31, 2024 | 56,753.00 |
| Dec 31, 2023 | 46,544.00 |
| Sep 30, 2023 | 71,759.00 |
| Jun 30, 2023 | 97,840.00 |
| Mar 31, 2023 | 161,817.00 |
| Dec 31, 2022 | 974,636.00 |
| Dec 31, 2020 | -69,469.00 |
| Sep 30, 2020 | 105,314.00 |
| Dec 31, 2019 | -967,676.00 |